What’s New and Exciting in Diagnostic Testing for Prostate Cancer?

  • Post comments:0 Comments
  • Reading time:5 mins read
You are currently viewing What’s New and Exciting in Diagnostic Testing for Prostate Cancer?

Prostate cancer is the most common cancer in men, and it’s the second-leading cause of cancer deaths. It can be very serious—especially if you don’t know you have it until it has spread.

The good news is that we now have more tools than ever to help find prostate cancer early. In fact, there are more tests available today than ever before.

Here’s a look at some of the newest diagnostic testing options available for prostate cancer, as well as how they may benefit you:

Prostate cancer is the most common non-skin cancer in American men. It is also one of the deadliest. According to a report from the Centers for Disease Control, it’s estimated that 29,430 men will die from prostate cancer this year.

In 2014, approximately 234,000 new cases of prostate cancer are expected to be diagnosed and about 2.5 million men in the United States will have a PSA test for prostate cancer. This number is based on an estimate from the Prostate Cancer Foundation that one in seven U.S. males will be diagnosed with prostate cancer in their lifetime.

Tests such as Prostate Specific Antigen (PSA) and digital rectal exams (DREs), are used to diagnose prostate cancer before any symptoms appear or even when symptoms are present. In some cases, these tests can even detect metastatic disease before any other signs or symptoms show up.

New advances in the diagnosis, treatment, and prevention of prostate cancer are covered in this article, which also looks at the role of diet, exercise, and vitamins in keeping healthy.

The prostate is a walnut-sized gland that sits between a man’s bladder and his penis. The prostate produces fluid that becomes part of semen, which carries sperm out of the testicles. Prostate cancer usually grows slowly and may not cause symptoms until it has reached an advanced stage.

Prostate cancer is one of the most common cancers in men. According to the National Cancer Institute (NCI), more than 220,000 new cases are expected to be diagnosed in 2018, with more than 27,000 cases resulting in death.

This number is expected to increase as the population grows and ages. The aging of the baby boomer generation will result in a higher incidence of prostate cancer as well as an increase in mortality from this disease. This has prompted the American Urological Association (AUA) to issue guidelines for screening for prostate cancer and monitoring its progression over time.

The AUA recommends that all men aged 55 to 69 years should have an initial PSA test and a digital rectal exam (DRE) within 3 years of each other. If the results are normal, then no further testing is required for at least 10 years.

Adults aged 40 and over who are at average risk for developing prostate cancer should speak with their health care providers about whether they should be tested for this disease. Men who are at high risk due to a family history or age can discuss with their clinicians whether they should start screening at an earlier age.”

Prostate cancer is the most common cancer among men. The prostate gland is located behind the wall of the bladder and in front of the rectum. It produces some of the fluid in semen, which carries sperm.

The main symptom is difficulty urinating, especially during the night. Other symptoms include a weak or interrupted urine flow and pain or discomfort in the lower back, hips, or upper thighs.

Treatment for prostate cancer may involve one or more of the following: surgery to remove the prostate, radiation therapy, drug therapy, or active surveillance (close observation).

Prostate cancer is a disease that affects the prostate gland which is located in the male reproductive system. This gland produces fluid that is present in semen and acts as a lubricant during sexual activity. Prostate cancer affects about one in every seven men and it’s estimated that there are more than 238,000 cases of prostate cancer diagnosed in the United States each year.

The most common symptoms of prostate cancer include difficulty urinating, blood in urine or semen, pain during urination and ejaculation, frequent erections and pain or discomfort in the back or pelvis. In advanced stages of the condition, other symptoms may include fatigue and weight loss.

Treatment for prostate cancer may vary according to your overall health and stage of the disease. In some instances, you may be treated with radiation therapy, surgery or anti-cancer drugs. The type of treatment will depend on test results as well as your overall medical condition. Your doctor will work with you to create an individualized treatment plan that meets your specific needs and goals.

Prostate cancer is one of the most common cancers in men. According to the American Cancer Society, about 161,000 new cases were reported in 2013, and about 27,500 people died from their prostate cancer.

The most common treatment for prostate cancer is androgen deprivation therapy (ADT), which involves cutting off the supply of testosterone to the cancer cells in order to slow down the growth of the tumor. The goal of ADT is to slow or stop the progression of the cancer so that surgical removal is not necessary.

For many years, doctors have believed that ADT causes a decrease in energy and sex drive as well as an increase in body fat and loss of muscle mass. However, many researchers are now questioning these assumptions.

Leave a Reply